Genetic Technologies Ltd ADR Each Representing 30 Ord Shares SPON

Sell:0.00pBuy:0.00pNo change

Prices delayed by at least 15 minutes
Sell:0.00p
Buy:0.00p
Change:No change
Prices delayed by at least 15 minutes
Sell:0.00p
Buy:0.00p
Change:No change
Prices delayed by at least 15 minutes

Company Information

About this company

Genetic Technologies Limited is an Australia-based diversified molecular diagnostics company. The Company is engaged in providing genomics-based tests on health, wellness and serious disease through its EasyDNA brand. The Company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The Company has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The Company's segments include EasyDNA and AffinityDNA. EasyDNA segment relates to EasyDNA branded test sales and expenses. AffinityDNA segment relates to AffinityDNA branded test sales and expenses.

Key people

Simon Morriss
Chief Executive Officer
Mark Ziirsen
Chief Financial Officer, Company Secretary
Kevin Camilleri
Chief Executive Officer - EasyDNA
Richard Allman
Chief Scientific Officer
Carl Stubbings
Chief Commercial Officer
Peter Irwin Rubinstein
Non-Executive Independent Chairman of the Board
Jerzy Muchnicki
Non-Independent Non-Executive Director
Lindsay Peter Wakefield
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    GTG
  • Location
    Australia
  • Sector
    Healthcare
  • Industry
    Healthcare Facilities
  • ISIN
    US37185R4065
  • Market cap
    GBX 0.00
  • Employees
    58
  • Shares in issue
    245.36m
  • Exchange
    Australian Stock Exchange Ltd
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.